Eotaxin levels and eosinophils in guinea pig broncho‐alveolar lavage fluid are increased at the onset of a viral respiratory infection
暂无分享,去创建一个
P. Sterk | G. Folkerts | F. Nijkamp | D. Conroy | J. Scheerens | T. J. Williams | H. J. van der Linde | H. van der Linde
[1] G. Canonica,et al. Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[2] W. Busse,et al. Virus-induced airway hyperresponsiveness and asthma. , 1998, American journal of respiratory and critical care medicine.
[3] G. Canonica,et al. Loratadine reduces the expression of ICAM‐1 , 1998, Allergy.
[4] G. Canonica,et al. Continuous versus on demand treatment with cetirizine for allergic rhinitis. , 1997, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[5] Q. Hamid,et al. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. , 1997, Journal of immunology.
[6] G. Canonica,et al. Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM‐1 expression , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[7] C. Mackay,et al. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. , 1997, Science.
[8] C. Mackay,et al. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. , 1997, The Journal of clinical investigation.
[9] S. Rankin,et al. Kinetics of Eotaxin Generation and Its Relationship to Eosinophil Accumulation in Allergic Airways Disease: Analysis in a Guinea Pig Model In Vivo , 1997, The Journal of experimental medicine.
[10] E. D. de KLERK,et al. Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. , 1997, American journal of respiratory and critical care medicine.
[11] G. Canonica,et al. Seasonal rhinitis and azelastine: long- or short-term treatment? , 1997, The Journal of allergy and clinical immunology.
[12] G. Canonica,et al. Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert anti‐allergic activity , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[13] G. Canonica,et al. Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: an antiallergic activity. , 1996, The Journal of allergy and clinical immunology.
[14] G. Canonica,et al. Topical ocular levocabastine reduces ICAM‐1 expression on epithelial cells both in vivo and in vitro , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[15] C. Mackay,et al. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils , 1996, The Journal of experimental medicine.
[16] G. Canonica,et al. Cetirizine reduces ICAM-I on epithelial cells during nasal minimal persistent inflammation in asymptomatic children with mite-allergic asthma. , 1996, International archives of allergy and immunology.
[17] G. Canonica,et al. Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. , 1995, The Journal of allergy and clinical immunology.
[18] T. Williams,et al. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo , 1995, The Journal of experimental medicine.
[19] G. Canonica,et al. Terfenadine exerts antiallergic activity reducing ICAM‐1 expression on nasal epithelial cells in patients with pollen allergy , 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[20] Stephen T Holgate,et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children , 1995, BMJ.
[21] G. Canonica,et al. ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation. , 1995, International archives of allergy and immunology.
[22] S. Johnston,et al. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. , 1995, American journal of respiratory and critical care medicine.
[23] G. Canonica,et al. Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge. , 1995, The Journal of allergy and clinical immunology.
[24] G. Canonica,et al. Allergen-specific challenge induces intercellular adhesion molecule 1 (ICAM-1 or CD54) on nasal epithelial cells in allergic subjects. Relationships with early and late inflammatory phenomena. , 1994, American journal of respiratory and critical care medicine.
[25] J. Hsuan,et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation , 1994, The Journal of experimental medicine.
[26] G. Canonica,et al. Adhesion molecules of allergic inflammation: recent insights into their functional roles , 1994, Allergy.
[27] T. Williams,et al. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. , 1993, Biochemical and biophysical research communications.
[28] T. Lee,et al. Adhesion molecules in allergic inflammation. , 1993, The American review of respiratory disease.
[29] R. Sorva,et al. Serum eosinophil cationic protein during treatment of asthma in children. , 1993, The Journal of allergy and clinical immunology.
[30] G. Folkerts,et al. Virus-induced changes in airway responsiveness, morphology, and histamine levels in guinea pigs. , 1993, The American review of respiratory disease.
[31] P. Span,et al. Virus‐induced airway hyperresponsiveness in the guinea‐pig: possible involvement of histamine and inflammatory cells , 1993, British journal of pharmacology.
[32] G. Canonica,et al. Allergic subjects express intercellular adhesion molecule--1 (ICAM-1 or CD54) on epithelial cells of conjunctiva after allergen challenge. , 1993, The Journal of allergy and clinical immunology.
[33] G. Folkerts,et al. Virus-induced airway hyperresponsiveness in guinea pigs in vivo: study of broncho-alveolar cell number and activity. , 1992, European journal of pharmacology.
[34] R. Lockey,et al. A possible role for adhesion molecules in asthma. , 1992, The Journal of allergy and clinical immunology.
[35] C. Wegner,et al. The role of intercellular adhesion molecule‐1 in chronic airway inflammation , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[36] I. Weissman,et al. Selectins: A family of adhesion receptors , 1991, Cell.
[37] Timothy A. Springer,et al. Adhesion receptors of the immune system , 1990, Nature.
[38] R. Rothlein,et al. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. , 1990, Science.
[39] A. Mcclelland,et al. The major human rhinovirus receptor is ICAM-1 , 1989, Cell.
[40] A. Vecchione,et al. Inflammatory changes in conjunctival scrapings after allergen provocation in humans. , 1988, The Journal of allergy and clinical immunology.
[41] H. Kita,et al. In Vitro: Synergistic Effects of Platelet-activating Factor and Eosinophil-active Cytokines , 1997 .
[42] B Dewald,et al. Human chemokines: an update. , 1997, Annual review of immunology.
[43] G. Folkerts,et al. Virus-induced airway hyperresponsiveness in guinea pigs is related to a deficiency in nitric oxide. , 1995, The Journal of clinical investigation.
[44] I. van Ark,et al. Antibody to interleukin-5 inhibits virus-induced airway hyperresponsiveness to histamine in guinea pigs. , 1995, American journal of respiratory and critical care medicine.
[45] S. Bonini,et al. 17 Late-phase ocular reaction induced by conjunctival allergen challenge. A dose-response study in humans , 1988 .